Sign Up to like & get
recommendations!
1
Published in 2018 at "Clinical Pharmacology in Drug Development"
DOI: 10.1002/cpdd.363
Abstract: Open‐label single‐ and double‐blind repeat‐dose studies in healthy female volunteers were conducted to investigate the pharmacokinetics (PK) and safety/tolerability of epelsiban total daily doses ranging from 600 to 900 mg. In 1 study (n =…
read more here.
Keywords:
healthy female;
gsk2395448;
epelsiban metabolite;
metabolite gsk2395448 ... See more keywords